Literature DB >> 6824366

Relationship of age and menopausal status to estrogen receptor content in primary carcinoma of the breast.

K S McCarty, J S Silva, E B Cox, G S Leight, S A Wells, K S McCarty.   

Abstract

The cytosolic estrogen receptor (CER) content of 1037 primary breast carcinomas was evaluated by sucrose density gradient analysis. Tumor specimens from premenopausal patients had significantly lower levels of CER (14.6 +/- 1.5 (mean +/- SEM) 8S binding fmole/mg protein) compared with carcinomas from postmenopausal patients (57.5 +/- 3.9 fmole/mg protein; p less than 0.001). The proportion of specimens with CER levels above threshold values of 3, 7, or 10 fmoles/mg protein were significantly higher for postmenopausal patients (72%, 63%, 59%, respectively) than for premenopausal patients (56%, 42%, 36%, p less than 0.001). When compared within half-decades, no statistically significant differences between premenopausal and postmenopausal patients were observed for mean, median, or rank sums of CER levels (p greater than 0.3). When patients were compared by half-decades, both mean and ranked sums of CER levels were significantly different (p less than 0.001). The proportion of specimens that demonstrated CER levels above a threshold value of 10 fmole/mg protein increased sequentially from a low of 13/51 (26%) for patients less than 35 years to a high of 60/81 (74%) for patients greater than 75 years.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6824366      PMCID: PMC1353098          DOI: 10.1097/00000658-198302000-00001

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  18 in total

1.  The prediction of hormonal dependency of mammary cancer.

Authors:  G E Block; E V Jensen; T Z Polley
Journal:  Ann Surg       Date:  1975-09       Impact factor: 12.969

Review 2.  Steroid hormone receptors in the regulation of differentiation. A review.

Authors:  K S McCarty; K S McCarty
Journal:  Am J Pathol       Date:  1977-03       Impact factor: 4.307

3.  Estrogen receptors and breast cancer response to adrenalectomy.

Authors:  E V Jensen; G E Block; S Smith; K Kyser; E R DeSombre
Journal:  Natl Cancer Inst Monogr       Date:  1971-12

4.  Molecular heterogeneity of cytosolic forms of estrogen receptors from human breast tumors.

Authors:  T E Kute; P Heidemann; J L Wittliff
Journal:  Cancer Res       Date:  1978-11       Impact factor: 12.701

5.  Estrogen and progesterone receptors in human breast cancer with concomitant assay of plasma 17beta-estradiol, progesterone, and prolactin levels.

Authors:  R Nagai; M Kataoka; S Kobayashi; K Ishihara; N Tobioka; K Nakashima; M Naruse; K Saito; S Sakuma
Journal:  Cancer Res       Date:  1979-05       Impact factor: 12.701

6.  Oestrogen receptors and peripheral serum levels of oestradiol-17beta in patients with mammary carcinoma.

Authors:  N O Theve; K Carlström; J A Gustafsson; S Gustafsson; B Nordenskjöld; H Sköldefors; O Wrange
Journal:  Eur J Cancer       Date:  1978-12       Impact factor: 9.162

7.  Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer.

Authors:  W A Knight; R B Livingston; E J Gregory; W L McGuire
Journal:  Cancer Res       Date:  1977-12       Impact factor: 12.701

8.  Concentration of unconjugated estrone and estradiol in peripheral plasma in nonpregnant women throughout the menstrual cycle, castrate and postmenopausal women and in men.

Authors:  D T Baird; A Guevara
Journal:  J Clin Endocrinol Metab       Date:  1969-02       Impact factor: 5.958

9.  Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer.

Authors:  J C Allegra; M E Lippman; E B Thompson; R Simon; A Barlock; L Green; K K Huff; H M Do; S C Aitken
Journal:  Cancer Res       Date:  1979-05       Impact factor: 12.701

10.  Estradiol and progesterone receptor levels in human breast adenocarcinoma in relation to plasma estrogen and progesterone levels.

Authors:  S Saez; P M Martin; C D Chouvet
Journal:  Cancer Res       Date:  1978-10       Impact factor: 12.701

View more
  9 in total

1.  Cognitive function in postmenopausal breast cancer patients one year after completing adjuvant endocrine therapy with letrozole and/or tamoxifen in the BIG 1-98 trial.

Authors:  Kelly-Anne Phillips; Julie Aldridge; Karin Ribi; Zhuoxin Sun; Alastair Thompson; Vernon Harvey; Beat Thürlimann; Fatima Cardoso; Olivia Pagani; Alan S Coates; Aron Goldhirsch; Karen N Price; Richard D Gelber; Jürg Bernhard
Journal:  Breast Cancer Res Treat       Date:  2010-11-03       Impact factor: 4.872

2.  Age as a confounding factor in the association of mammographic dysplasia and estrogen receptor concentration in breast cancer.

Authors:  N F Boyd; E Fishell; K Tonkin; B G Mobbs
Journal:  Breast Cancer Res Treat       Date:  1987-10       Impact factor: 4.872

Review 3.  Histologic types and hormone receptors in breast cancer in men: a population-based study in 282 United States men.

Authors:  H Stalsberg; D B Thomas; K A Rosenblatt; L M Jimenez; A McTiernan; A Stemhagen; W D Thompson; M G Curnen; W Satariano; D F Austin
Journal:  Cancer Causes Control       Date:  1993-03       Impact factor: 2.506

4.  Influence of the menstrual cycle on the concentrations of estrogen and progesterone receptors in primary breast cancer biopsies.

Authors:  C M Smyth; D E Benn; T S Reeve
Journal:  Breast Cancer Res Treat       Date:  1988-04       Impact factor: 4.872

5.  Should tamoxifen be a primary treatment choice for elderly breast cancer patients with locoregional disease?

Authors:  L Bergman; J A van Dongen; B van Ooijen; F E van Leeuwen
Journal:  Breast Cancer Res Treat       Date:  1995-04       Impact factor: 4.872

6.  Hormone treatment without surgery for patients aged 75 years or older with operable breast cancer.

Authors:  C J Wink; K Woensdregt; G A P Nieuwenhuijzen; M J C van der Sangen; S Hutschemaekers; J A Roukema; V C G Tjan-Heijnen; A C Voogd
Journal:  Ann Surg Oncol       Date:  2011-10-27       Impact factor: 5.344

7.  Risk factors for breast cancer by oestrogen receptor status: a population-based case-control study.

Authors:  J A Cooper; T E Rohan; E L Cant; D J Horsfall; W D Tilley
Journal:  Br J Cancer       Date:  1989-01       Impact factor: 7.640

8.  Stage and treatment variation with age in postmenopausal women with breast cancer: compliance with guidelines.

Authors:  L Wyld; D K Garg; I D Kumar; H Brown; M W R Reed
Journal:  Br J Cancer       Date:  2004-04-19       Impact factor: 7.640

9.  Prognostic factors for patients with hepatic metastases from breast cancer.

Authors:  L Wyld; E Gutteridge; S E Pinder; J J James; S Y Chan; K L Cheung; J F R Robertson; A J Evans
Journal:  Br J Cancer       Date:  2003-07-21       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.